Meticulous Research® announces that the mice model market is projected to reach $2.48 billion by 2030, growing at a CAGR of 6.5% from 2023 to 2030. Growth is driven by the advantages of using mice for studying human diseases, rising cancer prevalence, increased research grants, and the demand for personalized medicine. Technological advancements and innovations in mice models are expected to present significant opportunities.

Ethical concerns and regulatory restrictions may restrain market growth, along with challenges such as the lack of skilled personnel and high costs of mice models.

Future Outlook

The mice model market is segmented by type, services, technology, mode, application, end user, and geography. The study evaluates industry competitors and analyzes regional and country-level markets.

In 2023, the inbred mice segment is expected to account for the largest market share due to their unique genetic composition and reliable experimental results. Additionally, the breeding services segment is projected to hold the largest share, driven by the demand for breeding services to produce customized mice models for research in oncology and cardiovascular disease.